HIGHLIGHTS
- who: Artak Labadzhyan from the School of Medicine, Emory University, United States have published the article: Molecular targets in acromegaly, in the Journal: (JOURNAL)
- what: The molecular profile of acromegaly affords an array of potential targets that may predict tumor aggressiveness or treatment response.
- future: Cell-surface molecules and cell-cycle regulatory factors involved in the complex interplay of cell signaling and cell cycle regulation in somatotroph tumors including E-cadherin CDK inhibitors and EGFR TKIs hold potential as targets for new therapies in the future.
SUMMARY
Acromegaly is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.